Injection for adults facing obesity or overweight.
Monjaro (TIRZ/GLP1)
Injection for overweight and obese adults.
Monjaro, like other anti-diabetic drugs, mimics intestinal hormones, whose function is to regulate food intake, slow gastric digestion, increase the feeling of satiety and promote the secretion of insulin, an essential hormone in blood sugar regulation. What sets monjaro apart from other similar treatments is its ability to simultaneously activate two receptors involved in regulating blood sugar levels and appetite. According to Dr. Fannie Lajeunesse-Trempe, this dual action improves diabetes control and promotes weight loss. The receptors are likened to locks, requiring the right key to send the right signal to the body, which may be a natural hormone or a synthetic one, such as monjaro.
Who can benefit? In Canada, approved weight-loss medications can be prescribed to people with a body mass index (BMI) over 27 and other health problems, or with a BMI over 30. However, Health Canada recommends that they be used in conjunction with lifestyle changes to achieve results similar to those of the studies. Dr. Lajeunesse-Trempe stresses that medication is not a miracle solution
Research published in journals such as The Lancet, The New England Journal of Medicine and the Journal of the American Medical Association has demonstrated average weight losses of around 20% of initial weight in people suffering from obesity, with or without type 2 diabetes, and with associated complications such as hypertension or cardiovascular problems. In comparison, other drugs such as Ozempic lead to weight losses of around 6.7%, while Wegovy achieves losses of around 12.4%. Bariatric surgery can result in greater weight loss, from 25% to 30%.
Dr. Laurent Biertho believes that monjaro could, in some cases, replace bariatric surgery, reducing waiting lists, which have grown longer due to the COVID-19 pandemic. However, patients will probably need to take monjaro for a long time to maintain weight loss, requiring medical follow-up and lasting lifestyle changes.
Although promising, monjaro can cause side effects such as digestive disorders, although their intensity varies from patient to patient. What’s more, its efficacy can vary from one individual to another, and stopping treatment can often lead to weight regain.
In conclusion, the potential approval of monjaro by Health Canada represents a step forward in the treatment of obesity, a complex disease with repercussions on both physical and mental health.
Monjaro (TIRZ/GLP1)
Is it for me?
Monjaro questionnaire (TIRZ/GLP1):
- Do you struggle to control your food cravings?
- Is your relationship with food complicated?
- Need help managing your diet?
- Want to lose weight fast without fasting?
- Are you considering fasting but find it difficult?
- You want to reduce your alcohol consumption but can’t?
- Important events are coming up, like a wedding or a trip, and you want to look your best?
- You’re going on a trip and want to lose a few kilos?
- Feeling overweight and looking for motivation to change?
- You don’t like your reflection in the mirror and need support?
- Have you been living a sedentary life for too long?
- You don’t do any physical activity or sport and you feel tired?
- You want to get back into shape but need a helping hand?
- Do you want to feel better about yourself and have more energy?
- Do you feel pressure?
- Your health isn’t at its best and you want to change that?
- Do you have an unhealthy diet and want to change your habits?
- Do you want fast results?
- Are you ready to invest 45 days?
- Want to lose 20 to 40 pounds in 45 days?
- Do you know Ozempic?
If you answered yes to one or more of these questions, I’ve got the solution for you!
Lose up to 20% of your body fat
in just 12 weeks with TIRZ/GLP1.
- Reduces appetite
- Regulates blood sugar levels
- One injection a week is enough
BEFORE USING MONJARO
Before starting treatment with Monjaro, it’s crucial to consider a few things to ensure optimal results and your safety. Before taking Monjaro, please consider the following points:
ALLERGIES :
Inform your weight loss clinic or diabetes specialist of any allergies to Monjaro, other drugs or components of the medication.
MEDICAL HISTORY :
Report any diabetes-related kidney, pancreas or retina problems, or gastrointestinal disorders that may affect digestion.
PREGNANCY AND BREASTFEEDING :
Discuss your plans for pregnancy, current pregnancy or breast-feeding with your doctor, as Monjaro may have implications.
MONJARO INSTRUCTIONS
Monjaro is an injectable weight-loss solution, available in single-use ampoules. Patients can self-administer the drug into the stomach, thighs or back of the arms. Before injecting, it’s crucial to choose the right injection site and to inject directly at that point. Follow these steps carefully to ensure correct administration. Monjaro generally requires weekly injections for weight loss. Consult a diabetologist or healthcare professional to determine the appropriate dose and frequency for your specific needs.
PRECAUTIONS AND CONTRAINDICATIONS
Important points to consider for different patient groups:
– No dosage adjustment is required for patients with hepatic or renal impairment.
– Pregnant or breast-feeding women should avoid Monjaro because of the potential risks to the fetus or infant.
– People with a history of pancreatitis, kidney disorders, diabetic retinopathy, gastroparesis or medullary thyroid cancer should be cautious.
WHO CAN USE MONJARO?
You may be a good candidate for Monjaro if you’re overweight, have high cholesterol, high blood pressure, health complications, a BMI over 30 or type 2 diabetes.
SIDE EFFECTS
Monjaro may cause digestive side effects such as :
- diarrhea
- nausea
- headache/migraine
- vomiting
- upset stomach
- constipation
- loss of appetite
Monitor symptoms carefully and inform your doctor promptly if any side effects persist or become severe.
SCHEDULE OF EXPECTED RESULTS
Monjaro injections can immediately lower blood sugar levels. Weight-loss results can be seen after 8 to 12 weeks. Compared with semaglutide, Monjaro can reach target weight four weeks earlier. Significant weight loss is generally observed after 28 weeks.
WHO SHOULD AVOID MONJARO?
Monjaro may not be suitable for some people, including those with a specific medical history or those who are pregnant or breastfeeding. Consult a healthcare professional to determine if Monjaro is appropriate for you.
